A compound of formula (I): ** Formula ** or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph or a solvate thereof, wherein: ring A is independently phenyl, tetrahydronaphthalenyl or a heteroaryl of 5 to 10 members comprising carbon atoms and 1-4 heteroatoms selected from N, NRe, O and S； wherein said phenyl, tetrahydronaphthalenyl and heteroaryl are substituted with 0-1 R6 and 0-3 R7； R1 is independently selected from: - (CH2) m- (C3-6 carbocycle substituted with 0-2 Rb and 0-2 Rg), - (CH2) m- (5-6 membered heteroaryl comprising carbon atoms and 1 -4 heteroatoms selected from N, NRe, O and S, wherein said heteroaryl is substituted with 0-1 Rb and 0-2 Rg) and a C1-12 hydrocarbon chain substituted with 0-3 Ra； wherein said hydrocarbon chain can be linear or branched, saturated or unsaturated； R2 is independently selected from: H, halogen, C3-4 cycloalkyl, phenyl substituted with 0-2 Rh and C1-12 hydrocarbon chain substituted with 0-3 Ra； wherein said hydrocarbon chain can be linear or branched, saturated or unsaturated； R3 is independently selected from: - (CH2) n-X- (CH2) mR4, -CONHSO2R1, -NHCOX1SO2Ri, a 5- to 6-membered heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, NRe, O and S； wherein said heterocycle is substituted with 0-2 Rd； X is independently selected from: CONH and NHCO； X1 is independently C1-4 hydrocarbon chain optionally substituted with C1-4 alkyl or C3-4 cycloalkyl； R4 is independently selected from: C3-6 cycloalkyl substituted with 0-2 Rd, C3-6 cycloalkenyl substituted with 0-2 Rd, - (CH2) m- (phenyl substituted with 0-3 Rd) and a heterocycle from 5 to 6 members comprising carbon atoms and 1-4 heteroatoms selected from N, NRe, O and S； wherein said heterocycle is substituted with 0-2 Rd； R6 is independently selected from: halogen, C1-6 alkyl substituted with 0-2 Rh, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, - (CH2) m-C3-6 cycloalkyl, - (CH2) m -NRfRi, CN, ORi, SRi and 4- to 6-membered heterocycl
